TRIKAFTA (COPACKAGED) (elexacaftor, ivacaftor, tezacaftor; ivacaftor) Vertex pharms inc Patent: 8,354,427 Expiration: Jul 6, 2026 See More … For more […]
Drug Patent Expirations for the Week of July 5, 2026 Read Post »
Exelixis v. Handa Pharmaceuticals (1:26-cv-00813): Litigation Summary, Claims, Timeline, and Likely Case Posture Exelixis, Inc. v. Handa Pharmaceuticals, Inc., case
Exelixis, Inc. v. Handa Pharmaceuticals, Inc. Read Post »
Litigation Summary and Analysis: Azurity Pharmaceuticals, Inc. v. Aurobindo Pharma Limited (1:26-cv-00785) Executive Summary Azurity Pharmaceuticals, Inc. has filed a
Azurity Pharmaceuticals, Inc. v. Aurobindo Pharma Limited Read Post »
Vertex Pharmaceuticals Incorporated v. Squires (1:26-cv-01934): Litigation Summary, Claims, and Patent-Position Analysis Vertex Pharmaceuticals Incorporated has filed suit against Squires
Vertex Pharmaceuticals Incorporated v. Squires Read Post »
VALTURNA (aliskiren hemifumarate; valsartan) Novartis Patent: 8,168,616 Expiration: Jul 3, 2026 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of June 28, 2026 Read Post »
EVZIO (naloxone hydrochloride) Kaleo inc Patent: 10,960,155 Expiration: Jun 25, 2026 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of June 21, 2026 Read Post »
Generic and biosimilar companies used to have one venue to attack a brand patent: federal district court, under a clear-and-convincing-evidence
How to Use PTAB Data to Predict Which Brand Patents Will Crumble Read Post »
EVZIO (naloxone hydrochloride) Kaleo inc Patent: 10,960,155 Expiration: Jun 25, 2026 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of June 21, 2026 Read Post »
Sign in or create a free account to read this DrugPatentWatch article
